about
Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factorGINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancermiR-182 as a prognostic marker for glioma progression and patient survival.miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase.Transducin (β)-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.miR-486 sustains NF-κB activity by disrupting multiple NF-κB-negative feedback loops.TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.Upregulation of flotillin-1 promotes invasion and metastasis by activating TGF-β signaling in nasopharyngeal carcinoma.Flotillin-1 promotes tumor necrosis factor-α receptor signaling and activation of NF-κB in esophageal squamous cell carcinoma cells.Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway.AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma.miR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma.Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling.ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1.TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinomaWnt5a induces and maintains prostate cancer cells dormancy in boneEpigenetic silencing of SALL2 confers tamoxifen resistance in breast cancerOverexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancerCHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinomaNuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathwayAKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway
P50
Q21245752-01763C0E-23D4-40C9-B3E7-65DA4B8E225FQ33674751-981A35CC-284A-40E5-8546-30FB1B29C124Q33947151-729EA6C7-7468-4BD4-A6B2-E2740B148A3CQ34043212-5A7570BF-EC4E-402E-B146-14DC02A62E52Q35000357-7AA5F4E7-02B3-49AC-8DC5-CBE5348F3EAEQ36596742-27613E88-2471-4F16-BF1B-BDCE0D6CA318Q36659217-32EB0350-419D-4A21-8919-2C8923411AEBQ38383190-863AD788-B163-4933-9DAB-1E6F54295CE5Q39325356-D0F5D082-09B5-474D-A77F-828B0AA62A87Q39465501-CA9B8FF6-888B-4FB7-98CD-94566CC1A1D6Q41910456-801A2686-63A1-4D53-89FB-CCFD8CABD844Q43416243-13F37C3F-FE82-412F-BFE9-25A3A8361D8BQ47678044-A786C29D-1AFC-4208-8D50-71385DA8B176Q50590596-B97C5E7F-B50D-4267-AD67-DE93F4B9A387Q50897114-56843EF4-893B-4393-BAA7-010D429A069AQ51150626-930E862C-AB69-48C6-95E9-431AFAECECBEQ52597050-224A756F-5A4D-4F85-904B-5169B98083B6Q87516550-922D2A78-3189-4903-9057-E9E8ED60CF1FQ90796248-049C817B-20A8-40B9-92FD-5A3528D4381CQ90965745-EF7396A1-BFF1-4B38-905C-DA7E02223D37Q91172130-7E2F96EC-6197-4B5A-9FB9-05F2E422D74CQ92208813-7E551C7A-2DCB-4981-B57E-65E1B11BD03FQ92517775-37E657C3-C8BD-45E7-A998-16C022754C48Q92767263-75F94290-1BC5-4E23-B444-27D4C94D0D53
P50
description
investigador
@es
researcher
@en
name
Chuyong Lin
@en
type
label
Chuyong Lin
@en
prefLabel
Chuyong Lin
@en
P31
P496
0000-0003-4887-5386